Curtis B Thompson
Overview
Explore the profile of Curtis B Thompson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
1161
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cowell J, Printz M, Thompson C
Drug Metab Pers Ther
. 2021 Mar;
PMID: 33780198
Objectives: Drug-drug interaction studies for hyaluronidase safety assessments have evaluated only animal-derived enzyme preparations. We therefore set out to evaluate whether high-dose administration of two antihistamines, a potent corticosteroid, steroid...
2.
3.
Li X, Shepard H, Cowell J, Zhao C, Osgood R, Rosengren S, et al.
Clin Cancer Res
. 2018 Aug;
24(19):4798-4807.
PMID: 30084839
The tumor microenvironment (TME) evolves to support tumor progression. One marker of more aggressive malignancy is hyaluronan (HA) accumulation. Here, we characterize biological and physical changes associated with HA-accumulating (HA-high)...
4.
DuFort C, DelGiorno K, Carlson M, Osgood R, Zhao C, Huang Z, et al.
Biophys J
. 2016 May;
110(9):2106-19.
PMID: 27166818
Elevated interstitial fluid pressure can present a substantial barrier to drug delivery in solid tumors. This is particularly true of pancreatic ductal adenocarcinoma, a highly lethal disease characterized by a...
5.
Manuel E, Chen J, DApuzzo M, Lampa M, Kaltcheva T, Thompson C, et al.
Cancer Immunol Res
. 2015 Jul;
3(9):1096-107.
PMID: 26134178
Bacterial-based therapies are emerging as effective cancer treatments and hold promise for refractory neoplasms, such as pancreatic ductal adenocarcinoma (PDAC), which has not shown significant improvement in therapy for more...
6.
Kultti A, Zhao C, Singha N, Zimmerman S, Osgood R, Symons R, et al.
Biomed Res Int
. 2014 Aug;
2014:817613.
PMID: 25147816
Extensive accumulation of the glycosaminoglycan hyaluronan is found in pancreatic cancer. The role of hyaluronan synthases 2 and 3 (HAS2, 3) was investigated in pancreatic cancer growth and the tumor...
7.
DelGiorno K, Carlson M, Osgood R, Provenzano P, Brockenbough J, Thompson C, et al.
Cancer Cell
. 2014 Jul;
26(1):16-7.
PMID: 25026210
No abstract available.
8.
Huang Z, Zhao C, Chen Y, Cowell J, Wei G, Kultti A, et al.
J Immunol
. 2014 Apr;
192(11):5285-95.
PMID: 24778442
Hyaluronidase (Hyal) and low m.w. hyaluronan (LMW HA) fragments have been widely reported to stimulate the innate immune response. However, most hyaluronidases used were purified from animal tissues (e.g., bovine...
9.
Kultti A, Li X, Jiang P, Thompson C, Frost G, Shepard H
Cancers (Basel)
. 2013 Nov;
4(3):873-903.
PMID: 24213471
The tumor stroma, consisting of non-malignant cells and the extracellular matrix, undergoes significant quantitative and qualitative changes throughout malignant transformation and tumor progression. With increasing recognition of the role of...
10.
Kang L, Lantier L, Kennedy A, Bonner J, Mayes W, Bracy D, et al.
Diabetes
. 2013 Jan;
62(6):1888-96.
PMID: 23349492
Increased deposition of specific extracellular matrix (ECM) components is a characteristic of insulin-resistant skeletal muscle. Hyaluronan (HA) is a major constituent of the ECM. The hypotheses that 1) HA content...